(Q51004105)

26 March 2018

title

Kinetic behavior of the erythrocyte sodium-lithium countertransporter in nonnephropathic diabetic twins. (English)

1 reference

26 March 2018

author name string

Hardman TC

1

1 reference

26 March 2018

Dubrey SW

2

1 reference

26 March 2018

Leslie RD

3

1 reference

26 March 2018

Lant AF

4

1 reference

26 March 2018

publication date

1 October 1996

1 reference

26 March 2018

published in

Metabolism

1 reference

26 March 2018

volume

45

1 reference

26 March 2018

issue

10

1 reference

26 March 2018

page(s)

1203-1207

1 reference

26 March 2018

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Erythrocyte sodium-lithium countertransport: clinically useful, pathophysiologically instructive or just phenomenology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in subjects with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Increased sodium-lithium countertransport in red cells of patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Kinetics of sodium-lithium countertransport activity in patients with uncomplicated type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

A prospective study of sodium-lithium countertransport and hypertension in Utah

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990236-X

10.1016/S0026-0495(96)90236-X

7 January 2021

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018